Concepta Plc is an AIM-quoted pioneering UK healthcare company that has developed a proprietary product, myLotus, targeted at the personalized mobile health market with a primary focus on hormone testing and increasing a woman´s chances of naturally getting pregnant.
myLotus is currently the only consumer product which allows both quantitative and qualitative home (self-test) measurement of a woman´s personal luteinising hormone (LH) during ovulation and human chorionic gonadotropin (hCG) hormone level during pregnancy, facilitating higher conception rates and early diagnosis of fertility issues. myLotus allows women for the first time to identify their own personal ovulation hormone (LH) profile ´signature´ from a simple urine sample to identify their window of fertility and optimal time to naturally conceive.
The Company has received CE-mark certification for myLotus and has launched its first product in the UK. The Company is preparing plans to roll-out across the core EU countries in 2019.
Visit Concepta Plc at stall 114